Artal Group S.A.
- SEC CIK
- 0001053906
- 最新申報
- 2026/8/13
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/13 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 138
- 較 2021 年第 1 季 +5
- 總值
- $43.9 億
- 較 2021 年第 1 季 −$3.31 億 (−7.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| WWWW International, Inc. | COM | 14,818,300 | $5.36 億 | 12.2% | 00.0% | 不變 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $3.27 億 | 7.4% | 00.0% | 不變 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 850,000 | $2.92 億 | 6.6% | 00.0% | 不變 | 歷史 |
| SEERSeer, Inc. | COM CL A | 5,588,366 | $1.83 億 | 4.2% | 00.0% | 不變 | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 1,400,000 | $1.76 億 | 4.0% | 00.0% | 不變 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 500,000 | $1.51 億 | 3.4% | +50,000+11.1% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 850,000 | $1.37 億 | 3.1% | +125,000+17.2% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 750,000 | $1.27 億 | 2.9% | 00.0% | 不變 | 歷史 |
| FATEFate Therapeutics Inc | COM | 1,350,000 | $1.17 億 | 2.7% | +50,000+3.8% | 加碼 | 歷史 |
| RUBYRubius Therapeutics, Inc. | COM | 4,633,791 | $1.13 億 | 2.6% | −250,000−5.1% | 減碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 1,819,186 | $1.04 億 | 2.4% | 00.0% | 不變 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 1,100,000 | $9,152 萬 | 2.1% | −25,000−2.2% | 減碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $7,570 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 750,000 | $6,296 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 797,445 | $6,030 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 2,000,000 | $5,780 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 1,000,000 | $5,681 萬 | 1.3% | +350,000+53.8% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 2,000,000 | $5,124 萬 | 1.2% | −500,000−20.0% | 減碼 | 歷史 |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $4,586 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 500,000 | $4,121 萬 | 0.9% | +100,000+25.0% | 加碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 250,000 | $4,048 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 500,000 | $3,922 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| BHVNBiohaven Ltd. | COM | 400,000 | $3,883 萬 | 0.9% | +400,000 | 新進 | 歷史 |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $3,669 萬 | 0.8% | +1,500,000 | 新進 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 3,750,000 | $3,615 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 900,000 | $3,458 萬 | 0.8% | +100,000+12.5% | 加碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $3,400 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| AGENAgenus Inc | COM NEW | 6,000,000 | $3,294 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 1,317,954 | $3,157 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $3,103 萬 | 0.7% | −700,000−46.7% | 減碼 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $3,032 萬 | 0.7% | +2,064,262 | 新進 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 500,000 | $3,013 萬 | 0.7% | +500,000 | 新進 | 歷史 |
| DRNADicerna Pharmaceuticals Inc | COM | 800,000 | $2,986 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $2,734 萬 | 0.6% | −25,000−4.8% | 減碼 | 歷史 |
| TPTXTurning Point Therapeutics, Inc. | COM | 350,000 | $2,731 萬 | 0.6% | +37,300+11.9% | 加碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 994,047 | $2,550 萬 | 0.6% | −100,000−9.1% | 減碼 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $2,489 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 2,500,000 | $2,425 萬 | 0.6% | 00.0% | 不變 | – |
| CARAvis Budget Group, Inc. | COM | 300,000 | $2,337 萬 | 0.5% | −150,000−33.3% | 減碼 | 歷史 |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,500,000 | $2,333 萬 | 0.5% | −500,000−25.0% | 減碼 | 歷史 |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $2,321 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $2,208 萬 | 0.5% | 00.0% | 不變 | – |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $2,207 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $2,194 萬 | 0.5% | +450,000+60.0% | 加碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,549,513 | $2,176 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $2,151 萬 | 0.5% | +700,000 | 新進 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $2,111 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $2,083 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $2,007 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NEXINexImmune, Inc. | COM | 1,200,000 | $1,958 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $1,916 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $1,836 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $1,794 萬 | 0.4% | +200,000+25.0% | 加碼 | 歷史 |
| APTXAptinyx Inc. | COM | 6,116,493 | $1,731 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 550,000 | $1,715 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 275,000 | $1,676 萬 | 0.4% | +25,000+10.0% | 加碼 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $1,672 萬 | 0.4% | −500,000−11.1% | 減碼 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 850,000 | $1,666 萬 | 0.4% | +850,000 | 新進 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $1,630 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 450,000 | $1,561 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IQiQIYI, Inc. | SPONSORED ADS | 1,000,000 | $1,558 萬 | 0.4% | −25,000−2.4% | 減碼 | 歷史 |
| DLOdLocal Ltd | CLASS A COM | 295,000 | $1,550 萬 | 0.4% | +295,000 | 新進 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,750,000 | $1,477 萬 | 0.3% | 00.0% | 不變 | – |
| RLAYRelay Therapeutics, Inc. | COM | 400,000 | $1,464 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LFSTLifeStance Health Group, Inc. | COM | 500,000 | $1,393 萬 | 0.3% | +500,000 | 新進 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $1,387 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $1,378 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Translate Bio, Inc.89374L104 | COM | 500,000 | $1,377 萬 | 0.3% | −500,000−50.0% | 減碼 | – |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $1,374 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ADAGAdagene Inc. | ADS | 1,000,000 | $1,356 萬 | 0.3% | +200,000+25.0% | 加碼 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $1,352 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $1,296 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 600,000 | $1,251 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $1,231 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AGLagilon health, inc. | COM | 300,000 | $1,217 萬 | 0.3% | +300,000 | 新進 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 250,000 | $1,213 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $1,137 萬 | 0.3% | +700,000 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $1,105 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $1,084 萬 | 0.2% | +961,538+52.9% | 加碼 | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $1,050 萬 | 0.2% | +600,000+25.0% | 加碼 | 歷史 |
| CRISCuris Inc | COM NEW | 1,300,000 | $1,049 萬 | 0.2% | −504,729−28.0% | 減碼 | 歷史 |
| VORVor Biopharma Inc. | COM | 550,000 | $1,026 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 500,000 | $989.5 萬 | 0.2% | +500,000 | 新進 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $977.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,700,000 | $926.5 萬 | 0.2% | +675,000+65.9% | 加碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 100,000 | $879.6 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| YI111, Inc. | ADS | 966,349 | $877.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 450,000 | $869.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 700,000 | $858.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $841.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 400,000 | $831.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 2,250,000 | $823.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $795.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 1,000,000 | $793.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 1,803,858 | $791.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 400,000 | $786.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ARAVAravive, Inc. | COM | 1,311,291 | $784.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $781.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $746.3 萬 | 0.2% | 00.0% | 不變 | – |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 200,000 | $732.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 1 季之後清倉（14 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BNTXBioNTech SE | SPONSORED ADS | 900,000 | $9,827 萬 | 2.1% | 歷史 |
| INTCIntel Corp | Stock | 800,000 | $5,120 萬 | 1.1% | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 750,000 | $3,843 萬 | 0.8% | – |
| AVGOBroadcom Inc. | Stock | 75,000 | $3,478 萬 | 0.7% | 歷史 |
| BEKEKE Holdings Inc. | SPONSORED ADS | 600,000 | $3,419 萬 | 0.7% | 歷史 |
| CPNGCoupang, Inc. | CL A | 400,000 | $1,974 萬 | 0.4% | 歷史 |
| ZZillow Group, Inc. | CL C CAP STK | 100,000 | $1,296 萬 | 0.3% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 400,000 | $1,266 萬 | 0.3% | 歷史 |
| TMETencent Music Entertainment Group | SPON ADS | 550,000 | $1,127 萬 | 0.2% | 歷史 |
| TCOMTrip.com Group Ltd | ADS | 250,000 | $990.8 萬 | 0.2% | 歷史 |
| GDSGDS Holdings Ltd | SPONSORED ADS | 100,000 | $810.9 萬 | 0.2% | 歷史 |
| SHLSShoals Technologies Group, Inc. | CL A | 100,000 | $347.8 萬 | 0.1% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 75,000 | $194.3 萬 | <0.1% | 歷史 |
| MANUManchester United plc | ORD CL A | 12,488 | $19.7 萬 | <0.1% | 歷史 |